Treatment of actinic cheilitis with imiquimod 5% and a retractor on the lower lip: clinical and histological outcomes in 5 patients
Authors:
- Christopher McDonaldCMChristopher McDonald
- Sean LaverickSLSean Laverick
- Colin J. FlemingCFColin J. Fleming
- Sharon J. WhiteSWSharon J. White
- 1 September 2010
- journal article
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 48 (6) , 473-476
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of managementOral Oncology, 2009
- Photodynamic therapy: treatment of choice for actinic cheilitis?Dermatologic Therapy, 2008
- Actinic Keratosis: From the Skin to the LipJournal of Oral and Maxillofacial Surgery, 2008
- Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimodMolecular Immunology, 2008
- Actinic Cheilitis: Clinical and Histological FeaturesJournal of Oral and Maxillofacial Surgery, 2008
- Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% creamJournal of Dermatological Treatment, 2008
- A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinomaJournal of the American Academy of Dermatology, 2007
- Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the headJournal of the American Academy of Dermatology, 2007
- Topical imiquimod: effectiveness in intraepithelial melanoma of oral mucosaThe Lancet Oncology, 2006
- Actinic cheilitis: A review of 152 casesOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1999